56 related articles for article (PubMed ID: 34053430)
1. Detailed Chemistry Studies of
Eryilmaz K; Kilbas B
Curr Radiopharm; 2022; 15(1):76-83. PubMed ID: 34053430
[TBL] [Abstract][Full Text] [Related]
2. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes.
Hassan M; Bokhari TH; Lodhi NA; Khosa MK; Usman M
Chem Biol Drug Des; 2023 Nov; 102(5):1276-1292. PubMed ID: 37715360
[TBL] [Abstract][Full Text] [Related]
3. Actinium-225 targeted alpha particle therapy for prostate cancer.
Bidkar AP; Zerefa L; Yadav S; VanBrocklin HF; Flavell RR
Theranostics; 2024; 14(7):2969-2992. PubMed ID: 38773983
[TBL] [Abstract][Full Text] [Related]
4. A suitable time point for quantifying the radiochemical purity of
Kelly JM; Amor-Coarasa A; Sweeney E; Wilson JJ; Causey PW; Babich JW
EJNMMI Radiopharm Chem; 2021 Dec; 6(1):38. PubMed ID: 34928478
[TBL] [Abstract][Full Text] [Related]
5. Calcium Carbonate Core-Shell Particles for Incorporation of
Muslimov AR; Antuganov DO; Tarakanchikova YV; Zhukov MV; Nadporojskii MA; Zyuzin MV; Timin AS
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25599-25610. PubMed ID: 34028266
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Patient Doses of [
Nanabala R; Pillai MRA; Gopal B
Nucl Med Mol Imaging; 2022 Dec; 56(6):313-322. PubMed ID: 36425271
[TBL] [Abstract][Full Text] [Related]
7. Gamma counting protocols for the accurate quantification of
Castillo Seoane D; De Saint-Hubert M; Ahenkorah S; Saldarriaga Vargas C; Ooms M; Struelens L; Koole M
EJNMMI Radiopharm Chem; 2022 Oct; 7(1):28. PubMed ID: 36274098
[TBL] [Abstract][Full Text] [Related]
8. H
Kadassery KJ; King AP; Fayn S; Baidoo KE; MacMillan SN; Escorcia FE; Wilson JJ
Bioconjug Chem; 2022 Jun; 33(6):1222-1231. PubMed ID: 35670495
[TBL] [Abstract][Full Text] [Related]
9. Ac-EAZY! Towards GMP-Compliant Module Syntheses of
Pretze M; Kunkel F; Runge R; Freudenberg R; Braune A; Hartmann H; Schwarz U; Brogsitter C; Kotzerke J
Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358076
[TBL] [Abstract][Full Text] [Related]
10. Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals.
Martin S; Wendlinger L; Litvinenko A; Faizova R; Schottelius M
EJNMMI Radiopharm Chem; 2024 Mar; 9(1):23. PubMed ID: 38512591
[TBL] [Abstract][Full Text] [Related]
11. Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain.
Arani SS; Ghasemi S; Samani AB; Zafarghandi MS
Electron Physician; 2015; 7(1):977-84. PubMed ID: 26052408
[TBL] [Abstract][Full Text] [Related]
12. Actinium-225 Targeted Agents: Where Are We Now?
Mourtada F; Tomiyoshi K; Sims-Mourtada J; Mukai-Sasaki Y; Yagihashi T; Namiki Y; Murai T; Yang DJ; Inoue T
Brachytherapy; 2023; 22(6):697-708. PubMed ID: 37690972
[TBL] [Abstract][Full Text] [Related]
13. [The lacrimal apparatus as an organ at risk during radionuclide therapy].
Sheremeta MS; Trukhin AA; Yartsev VD; Yudakov DV; Korchagina MO; Gojaeva SA
Probl Endokrinol (Mosk); 2024 Feb; 70(1):13-17. PubMed ID: 38433537
[TBL] [Abstract][Full Text] [Related]
14. Coded aperture and Compton imaging for the development of
Frame E; Bobba K; Gunter D; Mihailescu L; Bidkar A; Flavell R; Vetter K
Med Phys; 2023 Oct; 50(10):6454-6468. PubMed ID: 37672346
[TBL] [Abstract][Full Text] [Related]
15. Production study of Fr, Ra and Ac radioactive ion beams at ISOLDE, CERN.
Jajčišinová E; Dockx K; Au M; Bara S; Cocolios TE; Chrysalidis K; Farooq-Smith GJ; Fedorov DV; Fedosseev VN; Flanagan KT; Heines M; Houngbo D; Johnson JD; Kellerbauer A; Kraemer S; Marsh BA; Popescu L; Ramos JP; Rothe S; Seliverstov MD; Sels S; Stegemann S; Stryjczyk M; Verelst V
Sci Rep; 2024 May; 14(1):11033. PubMed ID: 38744912
[TBL] [Abstract][Full Text] [Related]
16. Theranostic Imaging Surrogates for Targeted Alpha Therapy: Progress in Production, Purification, and Applications.
Nelson BJB; Wilson J; Andersson JD; Wuest F
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004486
[TBL] [Abstract][Full Text] [Related]
17. Peculiar Pattern of Response Following [225Ac]Ac-PSMA Therapy: A Case Report with 'PSA Pseudoregression' Response Pattern.
Al-Ibraheem A; Istatieh F; Abdlkadir AS; Abufara A; Sharaf B; Abu-Hijlih R; Al-Hajaj N; Salah S
Nuklearmedizin; 2024 May; ():. PubMed ID: 38760000
[No Abstract] [Full Text] [Related]
18. Is Actinium Really Happening?
Zimmermann R
J Nucl Med; 2023 Oct; 64(10):1516-1518. PubMed ID: 37591546
[No Abstract] [Full Text] [Related]
19. Calculation of radium-223 and actinium-225 α-emitter radiopharmaceuticals dose rates in treatment of metastatic castration-resistant prostate cancer.
Abbasi A; Dadashpour M; Alipourfard I
J Cancer Res Ther; 2021; 17(2):348-352. PubMed ID: 34121676
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of
Dumond ARS; Rodnick ME; Piert MR; Scott PJH
Curr Radiopharm; 2022; 15(2):96-103. PubMed ID: 34250876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
